These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 15659312)

  • 1. Cigarette smoke increases mucosal permeability in guinea pig trachea via tachykinin NK2 receptor activation.
    Tagawa A; Kaneko T; Nishiyama H; Shinohara T; Sato T; Geppetti P; Ishigatsubo Y
    Eur J Pharmacol; 2005 Jan; 507(1-3):223-8. PubMed ID: 15659312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tachykinins via Tachykinin NK(2) receptor activation mediate ozone-induced increase in the permeability of the tracheal mucosa in guinea-pigs.
    Fu L; Kaneko T; Ikeda H; Nishiyama H; Suzuki S; Okubo T; Trevisani M; Geppetti P; Ishigatsubo Y
    Br J Pharmacol; 2002 Mar; 135(5):1331-5. PubMed ID: 11877343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential activation of the epithelial and smooth muscle NK1 receptors by synthetic tachykinin agonists in guinea-pig trachea.
    Figini M; Emanueli C; Bertrand C; Sicuteri R; Regoli D; Geppetti P
    Br J Pharmacol; 1997 Jun; 121(4):773-81. PubMed ID: 9208147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heme oxygenase-1 inhibits cigarette smoke-induced increase in the tracheal mucosal permeability in guinea pigs in vivo.
    Tagawa A; Kaneko T; Shinohara T; Ueda A; Sato T; Ishigatsubo Y
    Inflamm Res; 2005 May; 54(5):229-34. PubMed ID: 15953995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of NK1 and NK2 receptors in pulmonary responses elicited by non-adrenergic, non-cholinergic vagal stimulation in guinea-pigs.
    Savoie C; Tousignant C; Rodger IW; Chan CC
    J Pharm Pharmacol; 1995 Nov; 47(11):914-20. PubMed ID: 8708985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SSR240600 [(R)-2-(1-[2-[4-[2-[3,5-bis(trifluoromethyl)phenyl]acetyl]-2-(3,4-dichlorophenyl)-2-morpholinyl]ethyl]- 4-piperidinyl)-2-methylpropanamide], a centrally active nonpeptide antagonist of the tachykinin neurokinin-1 receptor: I. biochemical and pharmacological characterization.
    Emonds-Alt X; Proietto V; Steinberg R; Oury-Donat F; Vigé X; Vilain P; Naline E; Daoui S; Advenier C; Le Fur G; Maffrand JP; Soubrié P; Pascal M
    J Pharmacol Exp Ther; 2002 Dec; 303(3):1171-9. PubMed ID: 12438541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MEN 10,627, a novel polycyclic peptide antagonist of tachykinin NK2 receptors.
    Maggi CA; Astolfi M; Giuliani S; Goso C; Manzini S; Meini S; Patacchini R; Pavone V; Pedone C; Quartara L
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1489-500. PubMed ID: 7996462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased blocking activity of combined tachykinin NK1- and NK2-receptor antagonists on hyperventilation-induced bronchoconstriction in the guinea pig.
    Corboz MR; Fernandez X; Hey JA
    Pulm Pharmacol Ther; 2008; 21(1):67-72. PubMed ID: 17239637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of tachykinins and capsaicin on the mechanical and electrical activity of the guinea-pig isolated trachea.
    Girard V; Félétou M; Advenier C; Canet E
    Br J Pharmacol; 1997 Nov; 122(5):841-8. PubMed ID: 9384499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological characterization of ZD6021: a novel, orally active antagonist of the tachykinin receptors.
    Rumsey WL; Aharony D; Bialecki RA; Abbott BM; Barthlow HG; Caccese R; Ghanekar S; Lengel D; McCarthy M; Wenrich B; Undem B; Ohnmacht C; Shenvi A; Albert JS; Brown F; Bernstein PR; Russell K
    J Pharmacol Exp Ther; 2001 Jul; 298(1):307-15. PubMed ID: 11408556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of tachykinin receptor antagonists in experimental neuropathic pain.
    Coudoré-Civiale MA; Courteix C; Eschalier A; Fialip J
    Eur J Pharmacol; 1998 Nov; 361(2-3):175-84. PubMed ID: 9865506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MEN 11420 (Nepadutant), a novel glycosylated bicyclic peptide tachykinin NK2 receptor antagonist.
    Catalioto RM; Criscuoli M; Cucchi P; Giachetti A; Gianotti D; Giuliani S; Lecci A; Lippi A; Patacchini R; Quartara L; Renzetti AR; Tramontana M; Arcamone F; Maggi CA
    Br J Pharmacol; 1998 Jan; 123(1):81-91. PubMed ID: 9484857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SR 140333 prevents potentiation by citric acid of plasma exudation induced by histamine in airways.
    Biyah K; Molimard M; Emonds-Alt X; Advenier C
    Eur J Pharmacol; 1996 Jul; 308(3):325-8. PubMed ID: 8858307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MEN15596, a novel nonpeptide tachykinin NK2 receptor antagonist.
    Cialdai C; Tramontana M; Patacchini R; Lecci A; Catalani C; Catalioto RM; Meini S; Valenti C; Altamura M; Giuliani S; Maggi CA
    Eur J Pharmacol; 2006 Nov; 549(1-3):140-8. PubMed ID: 16979621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GR159897, a potent non-peptide antagonist at tachykinin NK2 receptors.
    Beresford IJ; Sheldrick RL; Ball DI; Turpin MP; Walsh DM; Hawcock AB; Coleman RA; Hagan RM; Tyers MB
    Eur J Pharmacol; 1995 Jan; 272(2-3):241-8. PubMed ID: 7713168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SSR240600 [(R)-2-(1-[2-[4-[2-[3,5-bis(trifluoromethyl)phenyl]acetyl]-2-(3,4-dichlorophenyl)-2-morpholinyl]ethyl]-4-piperidinyl)-2-methylpropanamide], a centrally active nonpeptide antagonist of the tachykinin neurokinin 1 receptor: II. Neurochemical and behavioral characterization.
    Steinberg R; Alonso R; Rouquier L; Desvignes C; Michaud JC; Cudennec A; Jung M; Simiand J; Griebel G; Emonds-Alt X; Le Fur G; Soubrié P
    J Pharmacol Exp Ther; 2002 Dec; 303(3):1180-8. PubMed ID: 12438542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute neurogenic airway plasma exudation and edema induced by inhaled wood smoke in guinea pigs: role of tachykinins and hydroxyl radical.
    Lin YS; Kou YR
    Eur J Pharmacol; 2000 Apr; 394(1):139-48. PubMed ID: 10771046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of tachykinin NK1 and NK2 receptors in atropine-resistant colonic propulsion in anaesthetized guinea-pigs.
    Lecci A; Giuliani S; Tramontana M; Giorgio RD; Maggi CA
    Br J Pharmacol; 1998 May; 124(1):27-34. PubMed ID: 9630339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of receptors mediating contraction induced by tachykinins in the guinea-pig isolated common bile duct.
    Patacchini R; Barthó L; Maggi CA
    Br J Pharmacol; 1997 Dec; 122(8):1633-8. PubMed ID: 9422808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of tachykinin receptors in the uterus of the oestrogen-primed rat.
    Magraner J; Pinto FM; Anselmi E; Hernandez M; Perez-Afonso R; Martín JD; Advenier C; Candenas ML
    Br J Pharmacol; 1998 Jan; 123(2):259-68. PubMed ID: 9489614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.